146 related articles for article (PubMed ID: 9878126)
1. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice.
Arai Y; Takanashi H; Kitagawa H; Okayasu I
Cytokine; 1998 Nov; 10(11):890-6. PubMed ID: 9878126
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis.
Kwon KH; Murakami A; Hayashi R; Ohigashi H
Biochem Biophys Res Commun; 2005 Nov; 337(2):647-54. PubMed ID: 16202978
[TBL] [Abstract][Full Text] [Related]
3. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression.
Kwon KH; Murakami A; Tanaka T; Ohigashi H
Biochem Pharmacol; 2005 Feb; 69(3):395-406. PubMed ID: 15652231
[TBL] [Abstract][Full Text] [Related]
4. Phenyl methimazole suppresses dextran sulfate sodium-induced murine colitis.
Benavides U; Gonzalez-Murguiondo M; Harii N; Lewis CJ; Sakhalkar HS; Deosarkar SP; Kurjiaka DT; Dagia NM; Goetz DJ; Kohn LD
Eur J Pharmacol; 2010 Sep; 643(1):129-38. PubMed ID: 20550948
[TBL] [Abstract][Full Text] [Related]
5. The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation.
Loher F; Bauer C; Landauer N; Schmall K; Siegmund B; Lehr HA; Dauer M; Schoenharting M; Endres S; Eigler A
J Pharmacol Exp Ther; 2004 Feb; 308(2):583-90. PubMed ID: 14610233
[TBL] [Abstract][Full Text] [Related]
6. Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production.
Tamaki H; Nakamura H; Nishio A; Nakase H; Ueno S; Uza N; Kido M; Inoue S; Mikami S; Asada M; Kiriya K; Kitamura H; Ohashi S; Fukui T; Kawasaki K; Matsuura M; Ishii Y; Okazaki K; Yodoi J; Chiba T
Gastroenterology; 2006 Oct; 131(4):1110-21. PubMed ID: 17030181
[TBL] [Abstract][Full Text] [Related]
7. Modulating effect of Hesperidin on experimental murine colitis induced by dextran sulfate sodium.
Xu L; Yang ZL; Li P; Zhou YQ
Phytomedicine; 2009 Oct; 16(10):989-95. PubMed ID: 19386481
[TBL] [Abstract][Full Text] [Related]
8. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T
Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Mtgr1 sensitizes the colonic epithelium to dextran sodium sulfate-induced colitis.
Martinez JA; Williams CS; Amann JM; Ellis TC; Moreno-Miralles I; Washington MK; Gregoli P; Hiebert SW
Gastroenterology; 2006 Aug; 131(2):579-88. PubMed ID: 16890610
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice.
Ogawa A; Andoh A; Araki Y; Bamba T; Fujiyama Y
Clin Immunol; 2004 Jan; 110(1):55-62. PubMed ID: 14962796
[TBL] [Abstract][Full Text] [Related]
11. Establishment of dextran sulfate sodium-induced ulcerative colitis model in mice.
Wang QY; Chen CL; Wang JD; Lai ZS; Liu R; Zhang YL
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):608-10. PubMed ID: 12376288
[TBL] [Abstract][Full Text] [Related]
12. Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice.
Chen G; Yang Y; Liu M; Teng Z; Ye J; Xu Y; Cai X; Cheng X; Yang J; Hu C; Wang M; Cao P
J Ethnopharmacol; 2015 May; 166():149-56. PubMed ID: 25794808
[TBL] [Abstract][Full Text] [Related]
13. A new flavonoid derivative, dosmalfate, attenuates the development of dextran sulphate sodium-induced colitis in mice.
Villegas I; Alarcón de la Lastra C; Orjales A; La Casa C
Int Immunopharmacol; 2003 Dec; 3(13-14):1731-41. PubMed ID: 14636824
[TBL] [Abstract][Full Text] [Related]
14. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen mediates suppression of colon inflammation induced by dextran sodium sulfate.
Kajiya M; Silva MJ; Sato K; Ouhara K; Kawai T
Biochem Biophys Res Commun; 2009 Aug; 386(1):11-5. PubMed ID: 19486890
[TBL] [Abstract][Full Text] [Related]
16. Aquaporin expression is downregulated in a murine model of colitis and in patients with ulcerative colitis, Crohn's disease and infectious colitis.
Hardin JA; Wallace LE; Wong JF; O'Loughlin EV; Urbanski SJ; Gall DG; MacNaughton WK; Beck PL
Cell Tissue Res; 2004 Nov; 318(2):313-23. PubMed ID: 15338270
[TBL] [Abstract][Full Text] [Related]
17. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.
Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD
Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model.
Arafa HM; Hemeida RA; El-Bahrawy AI; Hamada FM
Food Chem Toxicol; 2009 Jun; 47(6):1311-7. PubMed ID: 19285535
[TBL] [Abstract][Full Text] [Related]
19. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
[TBL] [Abstract][Full Text] [Related]
20. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
Kimura I; Kawasaki M; Nagahama S; Matsuda A; Kataoka M; Kokuba Y
Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
